Skip to main content
Top
Published in: BMC Infectious Diseases 1/2018

Open Access 01-12-2018 | Research article

Treatment outcomes and factors affecting treatment outcomes of new patients with tuberculosis in Busan, South Korea: a retrospective study of a citywide registry, 2014–2015

Authors: Jeongha Mok, Daeseong An, Seoungjin Kim, Miyoung Lee, Changhoon Kim, Hyunjin Son

Published in: BMC Infectious Diseases | Issue 1/2018

Login to get access

Abstract

Background

This study investigated the treatment outcomes, and factors affecting the outcomes, of new tuberculosis (TB) patients in Busan, South Korea.

Methods

We retrospectively analysed the citywide TB registry data (collected for the Korean National TB Surveillance System) of new TB patients registered in Busan from January 2014 to December 2015.

Results

A total of 4732 patients were included in this study (mean age, 52.5 ± 19.9 years; 58.4% male). The overall treatment success rate was 83.9% (cured, 20.2%; completed, 63.7%); 8.0% of patients died, and 3.6% were lost to follow-up. In multivariate analyses, a higher rate of loss to follow-up was associated with foreign nationality, registered as TB-positive at least twice, and being in Q4 (fourth quintile) or Q5 (fifth quintile) of the regional deprivation index. Conversely, a lower rate of loss to follow-up was associated with female gender, smear-positive for pulmonary TB (PTB), and the treatment outcome being reported by a public health centre. Higher mortality was associated with old age (≥ 75 years), smear-positive PTB, treatment outcome being reported by the hospital, and being registered as TB-positive twice. Lower mortality was associated with female gender, treatment outcome being reported by a public health centre or clinic, and Q5 of the regional deprivation index.

Conclusions

Treatment outcomes of new TB patients were sub-optimal in Busan. TB control programs should maintain close monitoring and provide greater socioeconomic support to patients at high risk of poor treatment outcomes.
Literature
1.
go back to reference World Health Organization. Global tuberculosis report, 2017. Geneva: WHO; 2017. WHO/HTM/TB/2017.23 World Health Organization. Global tuberculosis report, 2017. Geneva: WHO; 2017. WHO/HTM/TB/2017.23
3.
go back to reference Kim JH, Yim JJ. Achievements in and challenges of tuberculosis control in South Korea. Emerg Infect Dis. 2015;21:1913–20.CrossRef Kim JH, Yim JJ. Achievements in and challenges of tuberculosis control in South Korea. Emerg Infect Dis. 2015;21:1913–20.CrossRef
4.
go back to reference World Health Organization. The END TB strategy. Geneva: WHO; 2015. WHO/HTM/TB/2015.19 World Health Organization. The END TB strategy. Geneva: WHO; 2015. WHO/HTM/TB/2015.19
5.
go back to reference World Health Organization. Definitions and reporting framework for tuberculosis-2013 revision. Geneva: WHO; 2013. WHO/HTM/TB/2013.2 World Health Organization. Definitions and reporting framework for tuberculosis-2013 revision. Geneva: WHO; 2013. WHO/HTM/TB/2013.2
6.
go back to reference Choi H, Lee M, Chen RY, Kim Y, Yoon S, Joh JS, et al. Predictors of pulmonary tuberculosis treatment outcomes in South Korea: a prospective cohort study, 2005-2012. BMC Infect Dis. 2014;14:360.CrossRef Choi H, Lee M, Chen RY, Kim Y, Yoon S, Joh JS, et al. Predictors of pulmonary tuberculosis treatment outcomes in South Korea: a prospective cohort study, 2005-2012. BMC Infect Dis. 2014;14:360.CrossRef
7.
go back to reference Kwon YS, Kim YH, Song JU, Jeon K, Song J, Ryu YJ, et al. Risk factors for death during pulmonary tuberculosis treatment in Korea: a multicenter retrospective cohort study. J Korean Med Sci. 2014;29:1226–31.CrossRef Kwon YS, Kim YH, Song JU, Jeon K, Song J, Ryu YJ, et al. Risk factors for death during pulmonary tuberculosis treatment in Korea: a multicenter retrospective cohort study. J Korean Med Sci. 2014;29:1226–31.CrossRef
8.
go back to reference Choi H, Chung H, Muntaner C, Lee M, Kim Y, Barry CE, et al. The impact of social conditions on patient adherence to pulmonary tuberculosis treatment. Int J Tuberc Lung Dis. 2016;20:948–54.CrossRef Choi H, Chung H, Muntaner C, Lee M, Kim Y, Barry CE, et al. The impact of social conditions on patient adherence to pulmonary tuberculosis treatment. Int J Tuberc Lung Dis. 2016;20:948–54.CrossRef
10.
go back to reference World Health Organization. Global tuberculosis report, 2016. Geneva: WHO; 2016. WHO/HTM/TB/2016.13 World Health Organization. Global tuberculosis report, 2016. Geneva: WHO; 2016. WHO/HTM/TB/2016.13
13.
go back to reference Kang HY, Yoo H, Park W, Go U, Jeong E, Jung KS, et al. Tuberculosis notification completeness and timeliness in the Republic of Korea during 2012-2014. Osong Public Health Res Perspect. 2016;7:320–6.CrossRef Kang HY, Yoo H, Park W, Go U, Jeong E, Jung KS, et al. Tuberculosis notification completeness and timeliness in the Republic of Korea during 2012-2014. Osong Public Health Res Perspect. 2016;7:320–6.CrossRef
15.
go back to reference Waitt CJ, Squire SB. A systematic review of risk factors for death in adults during and after tuberculosis treatment. Int J Tuberc Lung Dis. 2011;15:871–85.CrossRef Waitt CJ, Squire SB. A systematic review of risk factors for death in adults during and after tuberculosis treatment. Int J Tuberc Lung Dis. 2011;15:871–85.CrossRef
16.
go back to reference Chiang CY, Lee JJ, Yu MC, Enarson DA, Lin TP, Luh KT. Tuberculosis outcomes in Taipei: factors associated with treatment interruption for 2 months and death. Int J Tuberc Lung Dis. 2009;13:105–11.PubMed Chiang CY, Lee JJ, Yu MC, Enarson DA, Lin TP, Luh KT. Tuberculosis outcomes in Taipei: factors associated with treatment interruption for 2 months and death. Int J Tuberc Lung Dis. 2009;13:105–11.PubMed
17.
go back to reference Karo B, Hauer B, Hollo V, van der Werf MJ, Fiebig L, Haas W. Tuberculosis treatment outcome in the European Union and European economic area: an analysis of surveillance data from 2002-2011. Euro Surveill. 2015;20(49). Karo B, Hauer B, Hollo V, van der Werf MJ, Fiebig L, Haas W. Tuberculosis treatment outcome in the European Union and European economic area: an analysis of surveillance data from 2002-2011. Euro Surveill. 2015;20(49).
18.
go back to reference Zevallos M, Justman JE. Tuberculosis in the elderly. Clin Geriatr Med. 2003;19:121–38.CrossRef Zevallos M, Justman JE. Tuberculosis in the elderly. Clin Geriatr Med. 2003;19:121–38.CrossRef
19.
go back to reference Vasankari T, Holmström P, Ollgren J, Liippo K, Kokki M, Ruutu P. Risk factors for poor tuberculosis treatment outcome in Finland: a cohort study. BMC Public Health. 2007;7:291.CrossRef Vasankari T, Holmström P, Ollgren J, Liippo K, Kokki M, Ruutu P. Risk factors for poor tuberculosis treatment outcome in Finland: a cohort study. BMC Public Health. 2007;7:291.CrossRef
20.
go back to reference Farah MG, Tverdal A, Steen TW, Heldal E, Brantsaeter AB, Bjune G. Treatment outcome of new culture positive pulmonary tuberculosis in Norway. BMC Public Health. 2005;5:14.CrossRef Farah MG, Tverdal A, Steen TW, Heldal E, Brantsaeter AB, Bjune G. Treatment outcome of new culture positive pulmonary tuberculosis in Norway. BMC Public Health. 2005;5:14.CrossRef
21.
go back to reference Negin J, Abimbola S, Marais BJ. Tuberculosis among older adults-time to take notice. Int J Infect Dis. 2015;32:135–7.CrossRef Negin J, Abimbola S, Marais BJ. Tuberculosis among older adults-time to take notice. Int J Infect Dis. 2015;32:135–7.CrossRef
22.
go back to reference Kwon YS, Chi SY, Oh IJ, Kim KS, Kim YI, Lim SC, et al. Clinical characteristics and treatment outcomes of tuberculosis in the elderly: a case control study. BMC Infect Dis. 2013;13:121.CrossRef Kwon YS, Chi SY, Oh IJ, Kim KS, Kim YI, Lim SC, et al. Clinical characteristics and treatment outcomes of tuberculosis in the elderly: a case control study. BMC Infect Dis. 2013;13:121.CrossRef
23.
go back to reference Lefebvre N, Falzon D. Risk factors for death among tuberculosis cases: analysis of European surveillance data. Eur Respir J. 2008;31:1256–60.CrossRef Lefebvre N, Falzon D. Risk factors for death among tuberculosis cases: analysis of European surveillance data. Eur Respir J. 2008;31:1256–60.CrossRef
24.
go back to reference Valin N, Hejblum G, Borget I, Mallet HP, Antoun F, Che D, et al. Management and treatment outcomes of tuberculous patients, eastern Paris, France, 2004. Int J Tuberc Lung Dis. 2009;13:881–7.PubMed Valin N, Hejblum G, Borget I, Mallet HP, Antoun F, Che D, et al. Management and treatment outcomes of tuberculous patients, eastern Paris, France, 2004. Int J Tuberc Lung Dis. 2009;13:881–7.PubMed
25.
go back to reference Diel R, Niemann S. Outcome of tuberculosis treatment in Hamburg: a survey, 1997-2001. Int J Tuberc Lung Dis. 2003;7:124–31.PubMed Diel R, Niemann S. Outcome of tuberculosis treatment in Hamburg: a survey, 1997-2001. Int J Tuberc Lung Dis. 2003;7:124–31.PubMed
26.
go back to reference Caylà JA, Caminero JA, Rey R, Lara N, Vallés X, Galdós-Tangüis H. Working group on completion of tuberculosis treatment in Spain. Current status of treatment completion and fatality among tuberculosis patients in Spain. Int J Tuberc Lung Dis. 2004;8:458–64.PubMed Caylà JA, Caminero JA, Rey R, Lara N, Vallés X, Galdós-Tangüis H. Working group on completion of tuberculosis treatment in Spain. Current status of treatment completion and fatality among tuberculosis patients in Spain. Int J Tuberc Lung Dis. 2004;8:458–64.PubMed
27.
go back to reference Balasubramanian R, Garg R, Santha T, Gopi PG, Subramani R, Chandrasekaran V, et al. Gender disparities in tuberculosis: report from a rural DOTS programme in South India. Int J Tuberc Lung Dis. 2004;8:323–32.PubMed Balasubramanian R, Garg R, Santha T, Gopi PG, Subramani R, Chandrasekaran V, et al. Gender disparities in tuberculosis: report from a rural DOTS programme in South India. Int J Tuberc Lung Dis. 2004;8:323–32.PubMed
28.
go back to reference Hauer B, Brodhun B, Altmann D, Fiebig L, Loddenkemper R, Haas W. Tuberculosis in the elderly in Germany. Eur Respir J. 2011;38:467–70.CrossRef Hauer B, Brodhun B, Altmann D, Fiebig L, Loddenkemper R, Haas W. Tuberculosis in the elderly in Germany. Eur Respir J. 2011;38:467–70.CrossRef
29.
go back to reference Velayutham BR, Nair D, Chandrasekaran V, Raman B, Sekar G, Watson B, et al. Profile and response to anti-tuberculosis treatment among elderly tuberculosis patients treated under the TB control programme in South India. PLoS One. 2014;9:e88045.CrossRef Velayutham BR, Nair D, Chandrasekaran V, Raman B, Sekar G, Watson B, et al. Profile and response to anti-tuberculosis treatment among elderly tuberculosis patients treated under the TB control programme in South India. PLoS One. 2014;9:e88045.CrossRef
30.
go back to reference Pantoja A, Fitzpatrick C, Vassall A, Weyer K, Floyd K. Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis. Eur Respir J. 2013;42:708–20.CrossRef Pantoja A, Fitzpatrick C, Vassall A, Weyer K, Floyd K. Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis. Eur Respir J. 2013;42:708–20.CrossRef
31.
go back to reference Kigozi G, Heunis C, Chikobvu P, Botha S, van Rensburg D. Factors influencing treatment default among tuberculosis patients in a high burden province of South Africa. Int J Infect Dis. 2017;54:95–102.CrossRef Kigozi G, Heunis C, Chikobvu P, Botha S, van Rensburg D. Factors influencing treatment default among tuberculosis patients in a high burden province of South Africa. Int J Infect Dis. 2017;54:95–102.CrossRef
32.
go back to reference Kapella BK, Anuwatnonthakate A, Komsakorn S, Moolphate S, Charusuntonsri P, Limsomboon P, et al. Directly observed treatment is associated with reduced default among foreign tuberculosis patients in Thailand. Int J Tuberc Lung Dis. 2009;13:232–7.PubMed Kapella BK, Anuwatnonthakate A, Komsakorn S, Moolphate S, Charusuntonsri P, Limsomboon P, et al. Directly observed treatment is associated with reduced default among foreign tuberculosis patients in Thailand. Int J Tuberc Lung Dis. 2009;13:232–7.PubMed
33.
go back to reference Min GH, Kim Y, Lee JS, Oh JY, Hur GY, Lee YS, et al. Social and clinical characteristics of immigrants with tuberculosis in South Korea. Yonsei Med J. 2017;58:592–7.CrossRef Min GH, Kim Y, Lee JS, Oh JY, Hur GY, Lee YS, et al. Social and clinical characteristics of immigrants with tuberculosis in South Korea. Yonsei Med J. 2017;58:592–7.CrossRef
34.
go back to reference Muture BN, Keraka MN, Kimuu PK, Kabiru EW, Ombeka VO, Oguya F. Factors associated with default from treatment among tuberculosis patients in Nairobi province, Kenya: a case control study. BMC Public Health. 2011;11:696.CrossRef Muture BN, Keraka MN, Kimuu PK, Kabiru EW, Ombeka VO, Oguya F. Factors associated with default from treatment among tuberculosis patients in Nairobi province, Kenya: a case control study. BMC Public Health. 2011;11:696.CrossRef
35.
go back to reference Bhavnani D, Lancki N, Winter I, Macaraig M. Treatment outcomes of patients with tuberculosis in new York City. J Public Health Manag Pract. 2015;21:E11–8.CrossRef Bhavnani D, Lancki N, Winter I, Macaraig M. Treatment outcomes of patients with tuberculosis in new York City. J Public Health Manag Pract. 2015;21:E11–8.CrossRef
36.
go back to reference Tattevin P, Chapplain JM, Lesprit P, Billy C, Roblot F, Alfandari S, et al. Tuberculosis treatment duration in France: from guidelines to daily practice. Eur J Intern Med. 2006;17:427–9.CrossRef Tattevin P, Chapplain JM, Lesprit P, Billy C, Roblot F, Alfandari S, et al. Tuberculosis treatment duration in France: from guidelines to daily practice. Eur J Intern Med. 2006;17:427–9.CrossRef
37.
go back to reference Santha T, Garg R, Frieden TR, Chandrasekaran V, Subramani R, Gopi PG, et al. Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000. Int J Tuberc Lung Dis. 2002;6:780–8.PubMed Santha T, Garg R, Frieden TR, Chandrasekaran V, Subramani R, Gopi PG, et al. Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000. Int J Tuberc Lung Dis. 2002;6:780–8.PubMed
38.
go back to reference Kim HJ, Bai GH, Kang MK, Kim SJ, Lee JK, Cho SI, et al. A public–private collaboration model for treatment intervention to improve outcomes in patients with tuberculosis in the private sector. Tuberc Respir Dis. 2009;66:349–57.CrossRef Kim HJ, Bai GH, Kang MK, Kim SJ, Lee JK, Cho SI, et al. A public–private collaboration model for treatment intervention to improve outcomes in patients with tuberculosis in the private sector. Tuberc Respir Dis. 2009;66:349–57.CrossRef
39.
go back to reference Millett ER, Noel D, Mangtani P, Abubakar I, Kruijshaar ME. Factors associated with being lost to follow-up before completing tuberculosis treatment: analysis of surveillance data. Epidemiol Infect. 2013;141:1223–31.CrossRef Millett ER, Noel D, Mangtani P, Abubakar I, Kruijshaar ME. Factors associated with being lost to follow-up before completing tuberculosis treatment: analysis of surveillance data. Epidemiol Infect. 2013;141:1223–31.CrossRef
40.
go back to reference Karumbi J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev. 2015;29:CD003343. Karumbi J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev. 2015;29:CD003343.
41.
go back to reference Pasipanodya JG, Gumbo T. A meta-analysis of self-administered vs directly observed therapy effect on microbiologic failure, relapse, and acquired drug resistance in tuberculosis patients. Clin Infect Dis. 2013;57:21–31.CrossRef Pasipanodya JG, Gumbo T. A meta-analysis of self-administered vs directly observed therapy effect on microbiologic failure, relapse, and acquired drug resistance in tuberculosis patients. Clin Infect Dis. 2013;57:21–31.CrossRef
Metadata
Title
Treatment outcomes and factors affecting treatment outcomes of new patients with tuberculosis in Busan, South Korea: a retrospective study of a citywide registry, 2014–2015
Authors
Jeongha Mok
Daeseong An
Seoungjin Kim
Miyoung Lee
Changhoon Kim
Hyunjin Son
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2018
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-018-3574-y

Other articles of this Issue 1/2018

BMC Infectious Diseases 1/2018 Go to the issue